Objective: To identify areas where rates of HIV/AIDS and Tuberculosis (TB) are greatest in California. Methods: AIDS and TB data reported to the California surveillance registries from 1995 to 1998 were used to calculate gender-, and race/ethnicity-specific age-adjusted standardized incidence rates at state, county and zip code levels. The regional rates were compared to state rates and their statistical significance was assessed. Maps were used to better identify areas with high rates. Results: The rates varied for each condition by gender and race/ethnicity within different geographic regions. However, both African Americans (AA) and Hispanics (H) had the highest state adjusted rates of AIDS and TB per 100, 000. The AIDS rates for males (M) and females (F) in the interval years of 95-6 and 97-8 respectively were: AAM 212.3 & 151.8, HM 71.3 & 54.3, white (W) M 69.8 & 40.2, AAF 50.6 & 41.0, HF 9.1 & 7.2, WF 4.3 & 2.8. The corresponding rates for TB were AAM 53.1 & 37.2, HM 36.6 & 33.0, WM 5.9 & 4.7, AAF 26.6 & 22.2, HF 23.3 & 19.8, and WF 2.7 & 2.4. About 6% of counties had gender- and race/ethnicity-specific rates of both AIDS and TB that were significantly greater than the corresponding state rates. Conclusions: The results reflect the disproportionate incidence of AIDS and TB among African Americans and Hispanics in specific regions of California. The findings can assist public health officials target resources to the areas with the highest morbidity of these important public health conditions.
Learning Objectives: 1. To describe AIDS and TB co-morbidity in California. 2. To identify areas where rates of HIV/AIDS and Tuberculosis (TB) are greatest in California. 3. To identify gender- and race/ethinic-specific populations at highest risk for AIDS and TB co-morbidity
Keywords: HIV/AIDS, Co-morbid
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.